Use of substituted gamma-lactone compounds as pharmaceutical preparations

US6943181B2 · kind B2 · utility

Assignee

• GRUNENTHAL GMBH · DE

Inventors

• Corinna Sundermann · Aachen, DE
• Bernd Sundermann · Aachen, DE
• Michael Przewosny · Aachen, DE
• Hagen-Heinrich Hennies · Simmerath, DE

Key dates

• Filing date: Jan 5, 2004
• Grant date: Sep 13, 2005
• Expiry date: Jan 5, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to the use of substituted gamma-lactone compounds in the production of medicines for treating migraines, septic shock, neurodegenerative diseases, such as multiple sclerosis, Parkinsons, Alzheimers or Huntingtons disease, inflammations and related pain, cerebral ischaemia, diabetes, meningitis, arteriosclerosis, cancer, mycosis, or for healing wounds.